Dual hereditary jaundice: simultaneous occurrence of mutations causing Gilbert's and Dubin-Johnson syndrome
- PMID: 16012956
- DOI: 10.1053/j.gastro.2004.10.009
Dual hereditary jaundice: simultaneous occurrence of mutations causing Gilbert's and Dubin-Johnson syndrome
Abstract
Background & aims: Dubin-Johnson syndrome is recessively inherited, conjugated hyperbilirubinemia induced by mutations in the ABCC2/MRP2 gene encoding the canalicular transporter for conjugated bilirubin. Gilbert's syndrome is recessively inherited, unconjugated hyperbilirubinemia caused by decreased conjugation rate of bilirubin associated mostly with homozygous A(TA) 7 TAA variant of the TATAA-box in the UGT1A1 gene promoter. Our aim was to establish the molecular diagnosis in a 3-year-old male with atypical, intermittent, predominantly unconjugated, hyperbilirubinemia.
Methods: 99m Tc-HIDA cholescintigraphy was used for imaging the biliary tree. Expression of ABCC2/MRP2 protein in hepatocytes was investigated immunohistochemically. UGT1A1 and ABCC2/MRP2 genes were sequenced from genomic DNA, and the mutations were verified by fragment analysis, sequencing the cloned exons, and restriction fragment length polymorphism.
Results: Cholescintigraphy revealed delayed visualization of the gallbladder. A brown granular lipopigment differing from melanin-like pigment reported in Dubin-Johnson syndrome was present in hepatocytes, but, otherwise, liver histology was normal. ABCC2/MRP2 protein was not detected on the canalicular membrane of hepatocytes, and 2 novel mutations were found in the ABCC2/MRP2 gene: a heterozygous in-frame insertion-deletion mutation 1256insCT/delAAACAGTGAACCTGATG in exon 10 inherited from the father and a heterozygous deletion 4292delCA in exon 30 inherited from the mother. In addition, the patient was homozygous for -3279T>G and A(TA) 7 TAA mutations in the UGT1A1 gene promoter.
Conclusions: Our patient represents a case of digenic mixed hyperbilirubinemia-a distinct type of constitutive jaundice resulting from coinherited defects in ABCC2/MRP2 and UGT1A1 genes.
Similar articles
-
Genetic and biochemical study of dual hereditary jaundice: Dubin-Johnson and Gilbert's syndromes. Haplotyping and founder effect of deletion in ABCC2.Eur J Hum Genet. 2016 May;24(5):704-9. doi: 10.1038/ejhg.2015.181. Epub 2015 Sep 9. Eur J Hum Genet. 2016. PMID: 26350512 Free PMC article.
-
Concurrence of novel mutations causing Gilbert's and Dubin-Johnson syndrome with poor clinical outcomes in a Han Chinese family.J Hum Genet. 2023 Jan;68(1):17-23. doi: 10.1038/s10038-022-01086-1. Epub 2022 Oct 24. J Hum Genet. 2023. PMID: 36274106 Free PMC article.
-
Prolonged unconjugated hyperbilirubinemia associated with breast milk and mutations of the bilirubin uridine diphosphate- glucuronosyltransferase gene.Pediatrics. 2000 Nov;106(5):E59. doi: 10.1542/peds.106.5.e59. Pediatrics. 2000. PMID: 11061796
-
[Inherited disorders of bilirubin metabolism].Minerva Pediatr. 2005 Apr;57(2):53-63. Minerva Pediatr. 2005. PMID: 15985997 Review. Italian.
-
Gene replacement therapy for genetic hepatocellular jaundice.Clin Rev Allergy Immunol. 2015 Jun;48(2-3):243-53. doi: 10.1007/s12016-014-8454-7. Clin Rev Allergy Immunol. 2015. PMID: 25315738 Review.
Cited by
-
The apical conjugate efflux pump ABCC2 (MRP2).Pflugers Arch. 2007 Feb;453(5):643-59. doi: 10.1007/s00424-006-0109-y. Epub 2006 Jul 18. Pflugers Arch. 2007. PMID: 16847695 Review.
-
Mutation spectrum and biochemical features in infants with neonatal Dubin-Johnson syndrome.BMC Pediatr. 2020 Aug 5;20(1):369. doi: 10.1186/s12887-020-02260-0. BMC Pediatr. 2020. PMID: 32758197 Free PMC article.
-
Dubin-Johnson syndrome coinciding with colon cancer and atherosclerosis.World J Gastroenterol. 2013 Feb 14;19(6):946-50. doi: 10.3748/wjg.v19.i6.946. World J Gastroenterol. 2013. PMID: 23429660 Free PMC article.
-
New insights in bilirubin metabolism and their clinical implications.World J Gastroenterol. 2013 Oct 14;19(38):6398-407. doi: 10.3748/wjg.v19.i38.6398. World J Gastroenterol. 2013. PMID: 24151358 Free PMC article. Review.
-
Membrane transporters in drug development.Nat Rev Drug Discov. 2010 Mar;9(3):215-36. doi: 10.1038/nrd3028. Nat Rev Drug Discov. 2010. PMID: 20190787 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials